This startup develops medical devices that integrate AI into clinical practice to enhance the accuracy and efficiency of sperm selection processes. Their technology helps healthcare providers improve the success rates of infertility treatments, increasing the chances of conception for individuals and couples.
Funding
Funding not disclosed
Founders
Product
Problem
In vitro fertilization (IVF) laboratories face challenges in efficiently identifying and isolating high-quality sperm for procedures like intracytoplasmic sperm injection (ICSI), especially in cases of severe male-factor infertility where sperm are scarce. Traditional sperm selection methods can be time-consuming, labor-intensive, and potentially damaging to sperm DNA.
Solution
NeoGenix Biosciences develops and commercializes medical devices that leverage microfluidics and AI to improve sperm selection and handling in IVF. Their SpermGuide device uses biologically inspired microchannels to mimic natural sperm selection processes in the female reproductive tract, isolating high-quality sperm without centrifugation. The SpermSearch AI platform employs a convolutional neural network to instantly detect both motile and immotile sperm in real-time, streamlining sperm searches in testicular tissue or semen samples. These technologies aim to reduce clinical workload, minimize sperm damage, and ultimately improve patient outcomes in fertility treatments.
Target Audience
The primary customers are IVF clinics, embryologists, and clinicians seeking to improve sperm selection efficiency, reduce sperm damage, and enhance patient outcomes in fertility treatments.
Features
- **SpermGuide:** A microfluidic device that replicates the natural sperm selection process, isolating high-quality sperm in 15-30 minutes.
- Mimics the grooves of the cervix and fallopian tube to separate sperm based on their ability to navigate complex geometries.
- Eliminates the need for centrifugation, reducing the risk of DNA damage.
- **SpermSearch AI:** A convolutional neural network for real-time sperm detection in severe male-factor infertility cases.
- Detects both motile and immotile sperm in testicular tissue or semen samples.
- Reduces the time required to screen samples and select sperm for ICSI or sperm freezing.